Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
This rigorous quality control is our promise across our entire catalog of research peptides
On the basis of these mechanistic findings, we also developed targeted therapies that specifically prevent CXCL10IL18R1 binding and thereby protect ovaries from NRTP-induced damage
Because all SMA patients have 1 or more SMN2 gene copies, small molecule compounds that target SMN2 to produce increased quantities of full-length SMN protein from the existing SMN2 gene(s) are attractive therapeutic candidates
346-347, DOI: 10.1126/science.aav0556 Rogers, N., Creech, D., Eckhardt, S., Hanley, et al
US$ 24.53
US$ 26.53
US$ 26.41
US$ 23.99
US$ 20.56
US$ 23.19
US$ 25.33
